stock

Edwards Lifesciences Corp (EW)

Share

Stay up to date

Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. Edwards Lifesciences is driven by a passion for patients, dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape.

Financial Statements

Key Info

  • Industry: Surgical and Medical Instrument Manufacturing
  • Sector: Manufacturing
  • CEO Name: Michael Mussallem

Key Statistics

  • Stock Price: $117.72
  • Dividend Yield: 0%
  • Market Capitalization: $72,749,965,026
  • Shares Outstanding: 621,316,637
  • Number of Employees: 14,900
  • Trailing 12-Month EPS: $2.38
  • Trailing 12-Month DPS: $0
  • Payout Ratio: 0.0%

Important Dates

  • Next Earnings Date: 2022-04-19
  • Next Ex-Dividend Date:

Price Trends

  • Current Stock Price: $117.72
  • 52-week high: $131.73
  • 52-week low: $83.12
  • 200-day moving average: $114.81
  • 50-day moving average: $109.52

Performance

  • 1-Month Price Return: 3.6%
  • 3-Month Price Return: -10.4%
  • 6-Month Price Return: 3.1%
  • 1-Year Price Return: 41.3%
  • 2-Year Price Return: 79.2%
  • 5-Year Price Return: 274.2%

Visit the Passiv Stock Directory

Data provided by IEX Cloud

For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast